Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
[Bilateral effusion syndrome induced by chlorthalidon]
Gelareh Winter1, Ulrich Schaudig2, Birthe Stemplewitz2
1Klinik für Augenheilkunde, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Deutschland. ge.winter@asklepios.com.
Chlorthalidone, a diuretic, can cause uveal effusion leading to angle-closure glaucoma. Discontinuation of this medication resolved the effusion and glaucoma symptoms in a patient.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Uveal effusion is a condition characterized by fluid accumulation in the choroid.
- This can lead to secondary angle-closure glaucoma, causing significant visual impairment.
Observation:
- A 57-year-old male presented with headache, vertigo, and reduced visual acuity.
- Ocular examination revealed a myopic shift and angle-closure glaucoma attributed to uveal effusion.
Findings:
- The patient had recently started chlorthalidone as part of his antihypertensive regimen.
- Discontinuation of chlorthalidone resulted in the complete resolution of uveal effusion and associated glaucoma.
Implications:
- Chlorthalidone can induce uveal effusion and secondary angle-closure glaucoma.
- Prompt recognition and discontinuation of the offending agent are crucial for managing this condition.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

